Effects of physostigimine and modafinil post brain injury

ISRCTN ISRCTN38764966
DOI https://doi.org/10.1186/ISRCTN38764966
Secondary identifying numbers 02/212
Submission date
08/09/2005
Registration date
13/09/2005
Last edited
18/07/2016
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Injury, Occupational Diseases, Poisoning
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof David Menon
Scientific

Divison of Anaesthesia
University of Cambridge
Addenbrookes Hospital
Cambridge
CB2 2QQ
United Kingdom

Study information

Study designRandomised placebo controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet
Scientific titleEffects of physostigimine and modafinil post brain injury
Study objectivesInvestigation of the effects of physostigmine and modafinil on cognitive function post brain injury
Ethics approval(s)Cambridge Local Research Ethics Committee , 07/11/2002
Health condition(s) or problem(s) studiedSevere head trauma, subarachnoid haemorrhage
InterventionPatients are randomised to receive modafinil, physostigmine or placebo.
Intervention typeOther
Primary outcome measureCognitive changes noted on neuropsychology testing
Secondary outcome measuresBenefits noted on chronic therapy
Overall study start date02/01/2004
Completion date31/12/2010

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants60
Key inclusion criteriaPatients who have suffered brain injury
Key exclusion criteriaPast history of psychiatric illness
Date of first enrolment02/01/2004
Date of final enrolment31/12/2010

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Divison of Anaesthesia
Cambridge
CB2 2QQ
United Kingdom

Sponsor information

Addenbrookes NHS Trust Hospital + Cambridge University (UK)
Hospital/treatment centre

c/o Claudia Rizzini
R&D Department
Addenbrookes Hospital
Cambridge
CB2 2QQ
England
United Kingdom

ROR logo "ROR" https://ror.org/055vbxf86

Funders

Funder type

Hospital/treatment centre

Addenbrookes Hospital (UK) - Division of Anaesthesia

No information available

Medical Research Council (MRC) (UK) - Partially funded by MRC Grant No G9439390 ID 65883

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Editorial Notes

18/07/2016: No publications found, verifying study status with principal investigator.
23/03/2010: This trial has been extended from 30/12/2007 to 31/12/2010